SOD could convert ROS into hydrogen dioxide, which is then deactivated by catalase or glutathione (GSH)
Complementary GI support: BPC-157, with its gastric protective properties, may help buffer the GI effects of orforglipron
People taking GLP-1 medications had higher risks for 19 health outcomes, mostly involving digestive issues such as heartburn, nausea, vomiting, stomach pain and gastroparesis (stomach paralysis)
Among AOMs, prescribing increased substantially in September 2024 compared to June 2024 (+32.3%)
adults (roughly 1 in 8) report having taken a GLP-1 drug at some point
Te invitamos a visitarnos en la Fundacin Mexicana para la Fibromialgia, donde con gusto podemos ayudarte brindndote un diagnstico y soluciones adecuadas para ti